JAPAN HEALTH SCIENCES FOUNDATION
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Jan 11, 2018 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 293 Total Citation Count
- May 29, 1998 Earliest Filing
- 26 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2012/0231,490 Method Of Differentiation From Stem Cells To HepatocytesOct 22, 10Sep 13, 12[C12Q, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9683997 Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the sameDec 17, 15Jun 20, 17[A61K, C12Q, G01N, C07K]
9279161 Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the sameDec 26, 11Mar 08, 16[A61K, C12Q, G01N, C07K]
9023364 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirusJun 25, 08May 05, 15[A61K, C12N, C07K]
8340749 System for automatically minimizing cardiac oxygen consumption and cardiac disease treating system using the sameFeb 16, 07Dec 25, 12[A61B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0052,207 Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary AdenocarcinomaAbandonedMar 29, 11Feb 28, 13[C07H, A61K, G01N, A61P, C07K]
2012/0322,025 METHOD FOR FORMING DENTAL COATING AND DENTAL CAD/CAM DEVICEAbandonedJun 17, 11Dec 20, 12[A61B, A61C]
2012/0264,928 THERAPEUTIC PHARMACEUTICAL AGENT FOR DISEASES ASSOCIATED WITH DECREASE IN FUNCTION OF GNE PROTEIN, FOOD COMPOSITION, AND FOOD ADDITIVEAbandonedMay 14, 10Oct 18, 12[C07H]
2012/0231,970 COLON CANCER MARKER AND METHOD FOR TESTING FOR COLON CANCERAbandonedSep 30, 10Sep 13, 12[C07H, G01N, C40B]
2011/0243,910 MAMMALIAN RNA DEPENDENT RNA POLYMERASEAbandonedJul 07, 09Oct 06, 11[A61K, C12Q, C12N, C12M, G01N, A61P, C07K]
2011/0237,942 BIOIMAGING METHOD USING NEAR-INFRARED (NIR) FLUORESCENT MATERIALAbandonedMar 25, 11Sep 29, 11[G01J, A61B]
2010/0171,041 TOMOGRAPH, TOMOGRAPHY, TOMOGRAPHY PROGRAM, AND COMPUTER-READABLE RECORDING MEDIUM WHERE THE PROGRAM IS RECORDEDAbandonedJul 27, 06Jul 08, 10[G01T]
2010/0147,780 FILTER FOR FILTRATION AND RECOVERY OF SUSPENDED PARTICLES IN WATER, AND METHOD FOR FILTRATION AND RECOVERY OF SUSPENDED PARTICLES IN WATER AND METHOD FOR WATER QUALITY MANAGEMENT USING THE FILTERAbandonedAug 01, 07Jun 17, 10[B01J, C02F, B01D]
2010/0004,275 AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICSAbandonedJun 08, 09Jan 07, 10[A61K]
7601828 Estimation method, human estrogen receptor alpha gene, genomic DNA, and diagnostic markerExpiredMay 16, 06Oct 13, 09[C12Q, C12N]
2009/0175,825 INTERFERON ALPHA AND ANTISENSE K-RAS RNA COMBINATION GENE THERAPYAbandonedFeb 20, 09Jul 09, 09[A61K, A61P]
7514416 Interferon alpha and antisense K-ras RNA combination gene therapyExpiredApr 26, 05Apr 07, 09[A61K]
2009/0004,671 Marker Protein For Use In Diagnosis Of Pancreatic CancerAbandonedJan 26, 06Jan 01, 09[G01N, C07K]
2008/0295,189 Construction of Arterial Occlusive Disease Animal ModelAbandonedSep 12, 05Nov 27, 08[A01K]
2008/0227,802 Agent For Suppressing Development of Tolerance to Narcotic AnalgesicsAbandonedDec 26, 05Sep 18, 08[A61K]
2008/0195,161 Ventricular Fibrillation Preventing Apparatus and Defibrillating ApparatusAbandonedApr 11, 06Aug 14, 08[A61F, A61N]
2007/0254,332 Method for Readily Detecting Class C Beta-Lactamase-Producing BacteriaAbandonedDec 14, 04Nov 01, 07[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.